Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy

Medicina
Teruhiko Imamura

Abstract

Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impact on the responses to cardiac resynchronization therapy. The prognostic impact of cardiac resynchronization therapy on cardiac death including heart transplantation and durable ventricular assist device implantation is another concern.

References

Oct 28, 2019·The Annals of Thoracic Surgery·Felix G FernandezVinay Badhwar
Jan 18, 2020·Medicina·Paulius BašinskasTomas Kazakevičius

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Related Papers

British Journal of Hospital Medicine
V Cobb, M Thomas
Circulation
Ole-A Breithardt, Christoph Stellbrink
Cardiac Electrophysiology Clinics
Ranjan K Thakur, Andrea Natale
Nursing
Priscilla Moser Heffelfinger
© 2021 Meta ULC. All rights reserved